Flerie Q3 net loss more than doubles to SEK 281 million
Flerie’s net loss more than doubled to SEK 281 million in its January—September 2026 interim report. Net asset value fell 21% year over year to SEK 3.11 billion; portfolio shares’ total fair value dropped 12% to SEK 2.73 billion. During the quarter, portfolio company Empros Pharma’s net asset value was written down in